Skip to main content

Table 1 Survival time and sizes of PC-9-Br tumors based on drug treatment

From: Drug resistance occurred in a newly characterized preclinical model of lung cancer brain metastasis

Therapy

n

Survival (days)

Median size (mm2)

IQR (mm2)

Vehicle

114

42

0.1844

0.1129–0.3097

Cisplatin+Pemetrexed

96

45a

0.2492a

0.1305–0.4054

Cisplatin+Etoposide

117

51.5b,c

0.1093b,c

0.0533–0.2384

  1. Values bearing the letter a indicate no significant differences compared with vehicle, those labeled b denote a significant difference when compared with vehicle, and c denotes a significant difference when is cisplatin+etoposide compared with cisplatin+pemetrexed